| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $1,109,408 | 2 | 17 |
Sells | $4,137,784 | 10 | 83 |
| Hassanein Waleed H | President & CEO | 1 | $1M | 0 | $0 | $1M |
| Weill David | director | 1 | $109,058 | 2 | $1.22M | $-1.11M |
| Lovell Stephanie | director | 0 | $0 | 1 | $178,497 | $-178,497 |
| Corcoran Nicholas | See remarks | 0 | $0 | 1 | $412,630 | $-412,630 |
| Ranganath Anil P. | See remarks | 0 | $0 | 2 | $555,860 | $-555,860 |
| Gunderson Thomas J. | director | 0 | $0 | 1 | $722,377 | $-722,377 |
| Hernandez Gerardo | Chief Financial Officer | 0 | $0 | 3 | $1.05M | $-1.05M |
TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is the Organ Care System (OCS), an innovative, portable solution engineered to perfuse, optimize, and continuously monitor donor organs. This system leverages exclusive, tailored technology to meticulously recreate near-physiological conditions for these vital organs while they remain outside the …
Over the last 12 months, insiders at TransMedics Group, Inc. have bought $1.11M and sold $4.14M worth of TransMedics Group, Inc. stock.
On average, over the past 5 years, insiders at TransMedics Group, Inc. have bought $1.94M and sold $26.46M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Hassanein Waleed H (President & CEO) — $1M. Weill David (director) — $109,058.
The last purchase of 1,336 shares for transaction amount of $109,058 was made by Weill David (director) on 2026‑09‑11.
| 2026-09-11 | Weill David | director | 1,336 0.0038% | $81.63 | $109,058 | -3.87% | ||
| 2026-06-15 | Sale | Gunderson Thomas J. | director | 9,624 0.0277% | $75.06 | $722,377 | +3.88% | |
| 2026-03-04 | Sale | Hernandez Gerardo | Chief Financial Officer | 5,912 0.0172% | $147.21 | $870,306 | -45.31% | |
| 2026-03-04 | Sale | Weill David | director | 3,571 0.0104% | $146.82 | $524,294 | -45.31% | |
| 2026-03-04 | Sale | Lovell Stephanie | director | 1,193 0.0035% | $149.62 | $178,497 | -45.31% | |
| 2026-03-02 | Sale | Corcoran Nicholas | See remarks | 2,966 0.0083% | $139.12 | $412,630 | -44.85% | |
| 2026-03-02 | Sale | Hernandez Gerardo | Chief Financial Officer | 375 0.0011% | $139.12 | $52,170 | -44.85% | |
| 2026-03-02 | Sale | Ranganath Anil P. | See remarks | 864 0.0024% | $139.12 | $120,200 | -44.85% | |
| 2025-12-04 | Sale | Hernandez Gerardo | Chief Financial Officer | 920 0.0027% | $139.62 | $128,450 | -36.10% | |
| 2025-12-03 | Sale | Weill David | director | 5,000 0.0145% | $138.64 | $693,200 | -36.50% | |
| 2025-11-25 | Sale | Ranganath Anil P. | See remarks | 3,000 0.0097% | $145.22 | $435,660 | -38.37% | |
| 2025-11-17 | Hassanein Waleed H | President & CEO | 8,775 0.0258% | $114.00 | $1M | -19.09% | ||
| 2025-10-29 | Sale | Basile Edward M | director | 4,142 0.0123% | $130.45 | $540,324 | -27.72% | |
| 2025-08-07 | Hassanein Waleed H | President & CEO | 8,475 0.0249% | $116.25 | $985,209 | -0.32% | ||
| 2025-08-06 | Hassanein Waleed H | President & CEO | 8,400 0.0233% | $118.68 | $996,912 | -2.62% | ||
| 2025-08-04 | Sale | Basile Edward M | director | 4,143 0.0127% | $125.51 | $519,988 | -9.69% | |
| 2025-06-09 | Sale | Ranganath Anil P. | See remarks | 686 0.002% | $139.80 | $95,903 | -13.13% | |
| 2025-05-27 | Sale | Basile Edward M | director | 5,000 0.0145% | $126.45 | $632,250 | -4.78% | |
| 2025-05-23 | Sale | Weill David | director | 732 0.0022% | $123.88 | $90,680 | -1.26% | |
| 2025-05-09 | Sale | Basile Edward M | director | 6,000 0.0184% | $115.63 | $693,780 | +10.53% |
| Hassanein Waleed H | President & CEO | 495009 1.4276% | $33.33M | 3 | 42 | <0.0001% |
| Weill David | director | 16392 0.0473% | $1.1M | 3 | 7 | +16.41% |
| KANIA EDWIN M JR | director | 302893 0.8735% | $20.4M | 2 | 0 | <0.0001% |
| Basile Edward M | director | 2866 0.0083% | $192,996.44 | 1 | 11 | <0.0001% |
| Increased Positions | 248 | +61.23% | 4M | +10.19% |
| Decreased Positions | 174 | -42.96% | 4M | -9.82% |
| New Positions | 87 | New | 1M | New |
| Sold Out Positions | 46 | Sold Out | 1M | Sold Out |
| Total Postitions | 479 | +18.27% | 37M | +0.37% |
| Blackrock, Inc. | $654,134.00 | 15.68% | 5.33M | +107,952 | +2.07% | 2025-09-30 |
| Fmr Llc | $621,348.00 | 14.9% | 5.06M | +40,630 | +0.81% | 2025-09-30 |
| Vanguard Group Inc | $442,372.00 | 10.61% | 3.61M | +9,650 | +0.27% | 2025-09-30 |
| State Street Corp | $156,987.00 | 3.76% | 1.28M | -9,469 | -0.73% | 2025-09-30 |
| Ubs Am, A Distinct Business Unit Of Ubs Asset Management Ame | $131,216.00 | 3.15% | 1.07M | +113,817 | +11.91% | 2025-09-30 |
| Macquarie Group Ltd | $111,190.00 | 2.67% | 906,268 | -45,837 | -4.81% | 2025-09-30 |
| Ubs Group Ag | $105,030.00 | 2.52% | 856,063 | +379,925 | +79.79% | 2025-09-30 |
| Geode Capital Management, Llc | $99,817.00 | 2.39% | 813,571 | +8,921 | +1.11% | 2025-09-30 |
| Driehaus Capital Management Llc | $90,565.00 | 2.17% | 738,158 | -115,881 | -13.57% | 2025-09-30 |
| Goldman Sachs Group Inc | $86,322.00 | 2.07% | 703,578 | +386,403 | +121.83% | 2025-09-30 |